Chapter 15 Equine Viral Arteritis

  1. Timoney PJ, McCollum WH: Equine viral arteritis. Vet Clin North Am Equine Pract 9:295–309, 1993. PUBMED Abstract
  2. McCollum WH, Timoney P, Lee J Jr, et al: Features of an outbreak of equine viral arteritis on a breeding farm associated with abortion and fatal interstitial pneumonia in neonatal foals. In Equine Infectious Diseases VIII: Proceedings of the Eighth International Conference, 1998, pp 559–560.
  3. Timoney PJ: The increasing significance of international trade in equids and its influence on the spread of infectious diseases. Ann NY Acad Sci 916:55–60, 2000. PUBMED Abstract
  4. Timoney PJ: Equine viral arteritis: a disease of emerging significance? Equine Vet J 18:166–168, 1986. PUBMED Abstract
  5. Doll ER, Bryans JT, McCollum WH, et al: Isolation of a filterable agent causing arteritis of horses and abortion by mares; its differentiation from the equine abortion (influenza) virus. Cornell Vet 47:3–41, 1957. PUBMED Abstract
  6. Doll ER, Knappenberger RE, Bryans JT: An outbreak of abortion caused by the equine arteritis virus. Cornell Vet 47:69–75, 1957. PUBMED Abstract
  7. Jones TC, Doll ER, Bryans JT: The lesions of equine viral arteritis. Cornell Vet 47:52–68, 1957. PUBMED Abstract
  8. Burki F: Properties of the equine arteritis virus. Pathol Microbiol 28:939–949, 1965. PUBMED Abstract
  9. Burki F: Further properties of equine arteritis virus. Arch Gesamte Virusforsch 19:123–129, 1966. PUBMED Abstract
  10. Clark I: Transmission of pink-eye from apparently healthy stallions to mares. J Comp Pathol 5:261–264, 1892.
  11. Plateau E, Jacquet A: The propagation of influenza from stallion to mares. J Comp Pathol, 1:37–38, 1988.
  12. Cavanagh D: Nidovirales: a new order comprising Coronaviridae and Arteriviridae. Arch Virol 142:629–633, 1997. PUBMED Abstract
  13. Gorbalenya AE, Enjuanes L, Ziebuhr J, et al: Nidovirales: evolving the largest RNA virus genome. Virus Res 117:17–37, 2006. PUBMED Abstract
  14. Siddell SG, Ziebuhr J, Snijder EJ: Coronaviruses, toroviruses and arteriviruses. In Mahy BW, ter Meulen V, editors: Topley and Wilson's microbiology and microbial infections: virology, London, 2005, Hodder Arnold, pp 823–856.
  15. Snijder EJ, Meulenberg JJ: The molecular biology of arteriviruses. J Gen Virol 79(pt 5):961–979, 1998. PUBMED Abstract
  16. Van Dinten LC, den Boon JA, Wassenaar AL, et al: An infectious arterivirus cDNA clone: identification of a replicase point mutation that abolishes discontinuous mRNA transcription. Proc Natl Acad Sci USA 94:991–996, 1997. PUBMED Abstract
  17. Den Boon JA, Snijder EJ, Chirnside ED, et al: Equine arteritis virus is not a togavirus but belongs to the coronavirus-like superfamily. J Virol 65:2910–2920, 1991. PUBMED Abstract
  18. Miszczak F, Legrand L, Balasuriya UB, et al: Emergence of novel equine arteritis virus (EAV) variants during persistent infection in the stallion: origin of the 2007 French EAV outbreak was linked to an EAV strain present in the semen of a persistently infected carrier stallion. Virology 423:165–174, 2012. PUBMED Abstract
  19. Zhang J, Timoney PJ, Shuck KM, et al: Molecular epidemiology and genetic characterization of equine arteritis virus isolates associated with the 2006-2007 multi-state disease occurrence in the USA. J Gen Virol 91:2286–2301, 2010. PUBMED Abstract
  20. Balasuriya UB, Snijder EJ, Heidner HW, et al: Development and characterization of an infectious cDNA clone of the virulent Bucyrus strain of equine arteritis virus. J Gen Virol 88:918–924, 2007. PUBMED Abstract
  21. Balasuriya UB, Hedges JF, Smalley VL, et al: Genetic characterization of equine arteritis virus during persistent infection of stallions. J Gen Virol 85:379–390, 2004. PUBMED Abstract
  22. Ziebuhr J, Snijder EJ, Gorbalenya AE: Virus-encoded proteinases and proteolytic processing in the Nidovirales. J Gen Virol 81:853–879, 2000. PUBMED Abstract
  23. Van Dinten LC, Rensen S, Gorbalenya AE, et al: Proteolytic processing of the open reading frame 1b–encoded part of arterivirus replicase is mediated by nsp4 serine protease and is essential for virus replication. J Virol 73:2027–2037, 1999. PUBMED Abstract
  24. Zhang J, Timoney PJ, MacLachlan NJ, et al: Identification of an additional neutralization determinant of equine arteritis virus. Virus Res 138(1-2):4, 2008. PUBMED Abstract
  25. De Vries AA, Chirnside ED, Horzinek MC, et al: Structural proteins of equine arteritis virus. J Virol 66:6294–6303, 1992. PUBMED Abstract
  26. Snijder EJ, van Tol H, Pedersen KW, et al: Identification of a novel structural protein of arteriviruses. J Virol 73:6335–6345, 1999. PUBMED Abstract
  27. Snijder EJ, Spann WJM: Arteriviruses. In Knipe DM, Howley PM, Griffin DE, et al, editors: Fields Virology, Vol. 1, Philadelphia, 2007, Lippincott Williams & Wilkins, pp 1337–1355.
  28. Wieringa R, de Vries AA, van der Meulen J, et al: Structural protein requirements in equine arteritis virus assembly. J Virol 78:13019–13027, 2004. PUBMED Abstract
  29. Firth AE, Zevenhoven-Dobbe JC, Wills NM, et al: Discovery of a small arterivirus gene that overlaps the GP5 coding sequence and is important for virus production. J Gen Virol 92:1097–1106, 2011. PUBMED Abstract
  30. Snijder EJ, Dobbe JC, Spaan WJ: Heterodimerization of the two major envelope proteins is essential for arterivirus infectivity. J Virol 77:97–104, 2003. PUBMED Abstract
  31. de Vries AA, Post SM, Raamsman MJ, et al: The two major envelope proteins of equine arteritis virus associate into disulfide-linked heterodimers. J Virol 69:4668–4674, 1995. PUBMED Abstract
  32. Balasuriya UB, Dobbe JC, Heidner HW, et al: Characterization of the neutralization determinants of equine arteritis virus using recombinant chimeric viruses and site-specific mutagenesis of an infectious cDNA clone. Virology 321:235–246, 2004. PUBMED Abstract
  33. Hedges JF, Balasuriya UB, Topol JB, et al: Genetic variation of ORFs 3 and 4 of equine arteritis virus. Adv Exp Med Biol 494:69–72, 2001. PUBMED Abstract
  34. Hedges JF, Balasuriya UB, Timoney PJ, et al: Genetic divergence with emergence of novel phenotypic variants of equine arteritis virus during persistent infection of stallions. J Virol 73:3672–3681, 1999. PUBMED Abstract
  35. Balasuriya UB, Timoney PJ, McCollum WH, et al: Phylogenetic analysis of open reading frame 5 of field isolates of equine arteritis virus and identification of conserved and nonconserved regions in the GL envelope glycoprotein. Virology 214:690–697, 1995. PUBMED Abstract
  36. Stadejek T, Bjorklund H, Bascunana CR, et al: Genetic diversity of equine arteritis virus. J Gen Virol 80(pt 3):691–699, 1999. PUBMED Abstract
  37. Balasuriya UB, Maclachlan NJ: The immune response to equine arteritis virus: potential lessons for other arteriviruses. Vet Immunol Immunopathol 102:107–129, 2004. PUBMED Abstract
  38. Balasuriya UB, Patton JF, Rossitto PV, et al: Neutralization determinants of laboratory strains and field isolates of equine arteritis virus: identification of four neutralization sites in the amino-terminal ectodomain of the G(L) envelope glycoprotein. Virology 232:114–128, 1997. PUBMED Abstract
  39. Balasuriya UB, Rossitto PV, DeMaula CD, et al: A 29K envelope glycoprotein of equine arteritis virus expresses neutralization determinants recognized by murine monoclonal antibodies. J Gen Virol 74(pt 11):2525–2529, 1993. PUBMED Abstract
  40. Deregt D, de Vries AA, Raamsman MJ, et al: Monoclonal antibodies to equine arteritis virus proteins identify the GL protein as a target for virus neutralization. J Gen Virol 75(pt 9):2439–2444, 1994. PUBMED Abstract
  41. Chirnside ED, de Vries AA, Mumford JA, et al: Equine arteritis virus–neutralizing antibody in the horse is induced by a determinant on the large envelope glycoprotein GL. J Gen Virol 76(pt 8):1989–1998, 1995. PUBMED Abstract
  42. Glaser AL, de Vries AA, Dubovi EJ: Comparison of equine arteritis virus isolates using neutralizing monoclonal antibodies and identification of sequence changes in GL associated with neutralization resistance. J Gen Virol 76(pt 9):2223–2233, 1995. PUBMED Abstract
  43. Balasuriya UB, Hedges JF, Nadler SA, et al: Genetic stability of equine arteritis virus during horizontal and vertical transmission in an outbreak of equine viral arteritis. J Gen Virol 80(pt 8):1949–1958, 1999. PUBMED Abstract
  44. Patton JF, Balasuriya UB, Hedges JF, et al: Phylogenetic characterization of a highly attenuated strain of equine arteritis virus from the semen of a persistently infected standardbred stallion. Arch Virol 144:817–827, 1999. PUBMED Abstract
  45. Balasuriya UB, Evermann JF, Hedges JF, et al: Serologic and molecular characterization of an abortigenic strain of equine arteritis virus isolated from infective frozen semen and an aborted equine fetus. J Am Vet Med Assoc 213:1586–1589, 1998. PUBMED Abstract
  46. Murphy TW, McCollum WH, Timoney PJ, et al: Genomic variability among globally distributed isolates of equine arteritis virus. Vet Microbiol 32:101–115, 1992. PUBMED Abstract
  47. McCollum WH, Timoney PJ: Experimental observations on the virulence of isolates of equine arteritis virus. In Equine Infectious Diseases VIII: Proceedings of the Eighth International Conference, 1998, pp 558–559.
  48. Zhang J, Go YY, MacLachlan NJ, et al: Amino acid substitutions in the structural or nonstructural proteins of a vaccine strain of equine arteritis virus are associated with its attenuation. Virology 378:355–362, 2008. PUBMED Abstract
  49. Go YY, Zhang J, Timoney PJ, et al: Complex interactions between the major and minor envelope proteins of equine arteritis virus determine its tropism for equine CD3+ T lymphocytes and CD14+ monocytes. J Virol 84:4898–4911, 2010. PUBMED Abstract
  50. Zhang J, Timoney PJ, MacLachlan NJ, et al: Persistent equine arteritis virus infection in HeLa cells. J Virol 82:8456–8464, 2008. PUBMED Abstract
  51. Burki F: The virology of equine arteritis virus. In Equine Infectious Diseases II: Proceedings of the Second International Conference, 1970, pp 125–129.
  52. Gerber H, Steck F, Hofer B, et al: Clinical and serological investigation on equine viral arteritis. In Equine Infectious Diseases IV: Proceedings of the Fourth International Conference, 1978, pp 461–465.
  53. Nowotny N: First isolation of equine arteritis virus (EAV) from three aborted equine fetuses from three different premises in Austria. In Equine Infectious Diseases VI: Proceedings of the Sixth International Conference, 1992, p 328.
  54. Nowotny N, Burki F: Three cases of virus isolation from horse fetuses diagnosed with equine arteritis virus (EAV) abortion from stud farms with different breeds. Berl Munch Tierarztl Wochenschr 105:181–187, 1992. PUBMED Abstract
  55. Golnik W, Moraillon A, Golnik J: Identification and antigenic comparison of equine arteritis virus isolated from an outbreak of epidemic abortion of mares. Zentralbl Veterinarmed B 33:413–417, 1986. PUBMED Abstract
  56. Golnik W, Michalska Z, Michalak T: Natural equine viral arteritis in foals. Schweiz Arch Tierheilkd 123:523–533, 1981. PUBMED Abstract
  57. Autorino GL, Rosati R, Ferrari G, et al: Equine arteritis virus isolation from stallions in Italy. In Equine Infectious Diseases VI: Proceedings of the Sixth International Conference, 1992, p 303.
  58. Cancellotti FM, Renzi M: Equine arteritis virus (EAV) in Italy: current situation. In Equine Infectious Diseases VI: Proceedings of the Sixth International Conference, 1992, p 305.
  59. Camm IS, Thursby-Pelham C: Equine viral arteritis in Britain. Vet Rec 132:615, 1993. PUBMED Abstract
  60. Wood JL, Chirnside ED, Mumford JA, et al: First recorded outbreak of equine viral arteritis in the United Kingdom. Vet Rec 136:381–385, 1995. PUBMED Abstract
  61. Higgins AJ: Equine viral arteritis: a challenge for the British horse industry. Br Vet J 149:305–306, 1993. PUBMED Abstract
  62. Higgins A: Equine viral arteritis. Vet Rec 132:591, 1993. PUBMED Abstract
  63. Monreal L, Villatoro AJ, Hooghuis H, et al: Clinical features of the 1992 outbreak of equine viral arteritis in Spain. Equine Vet J 27:301–304, 1995. PUBMED Abstract
  64. Van Gorkom LP, van Wessum R, van den Hoven R: An outbreak of equine arteritis virus infection in a riding school. Tijdschr Diergeneeskd 119:30–32, 1994. PUBMED Abstract
  65. Clayton H: 1986 outbreak of EAV in Alberta, Canada. J Equine Vet Sci 7:101, 1987.
  66. Klavano GG: Equine viral arteritis. Can Vet J 28:281, 1987.
  67. Collins JK, Kari S, Ralston SL, et al: Equine viral arteritis in a veterinary teaching hospital. Prev Vet Med 4:389–397, 1987.
  68. Dwyer R, Harrison L, Haughey D: Racetrack outbreak of EAV. Equine Dis Q 2:2–4, 1993.
  69. McCollum WH, Bryans JT: Serological identification of infection by equine arteritis virus in horses of several countries. In Proceedings of the third Interantional Conference of Equine Infectious Diseases, Paris, 1973, S Karger (Basel), pp 256–263.
  70. McCollum WH, Swerczek TW: Studies of an epizootic of equine viral arteritis in race horses. Equine Vet J 2:293–299, 1978.
  71. Timoney PJ: Clinical, virological, and epidemiological features of the 1984 outbreak of equine viral arteritis in the Thoroughbred population in Kentucky. In Proceedings of the Grayson Foundation International Conference of Thoroughbred Breeders Organizations, 1984, pp 24–33.
  72. Timoney PJ, McCollum WH, Roberts AW, et al: Status of equine viral arteritis in Kentucky, 1985. J Am Vet Med Assoc 191:36–39, 1987. PUBMED Abstract
  73. Timoney PJ, McCollum WH, Roberts AW, et al: Status of equine viral arteritis in Kentucky for 1986. Vet Rec 120:282, 1987. PUBMED Abstract
  74. Wood JL, Newton JR: Serological study of equine viral arteritis in standard-breds in the UK. Vet Rec 136:499, 1995. PUBMED Abstract
  75. Larsen LE, Storgaard T, Holm E: Phylogenetic characterisation of the G(L) sequences of equine arteritis virus isolated from semen of asymptomatic stallions and fatal cases of equine viral arteritis in Denmark. Vet Microbiol 80:339–346, 2001. PUBMED Abstract
  76. Zhang J, et al: Genetic variation and phylogenetic analysis of 22 French isolates of equine arteritis virus. Arch Virol 152:1977–1994, 2007.
  77. Pronost S, Pitel PH, Miszczak F, et al: Description of the first recorded major occurrence of equine viral arteritis in France. Equine Vet J 42:713–720, 2010. PUBMED Abstract
  78. Paweska JT, Binns MM, Woods PS, et al: A survey for antibodies to equine arteritis virus in donkeys, mules and zebra using virus neutralisation (VN) and enzyme linked immunosorbent assay (ELISA). Equine Vet J 29:40–43, 1997. PUBMED Abstract
  79. Paweska JT, Barnard BJ: Serological evidence of equine arteritis virus in donkeys in South Africa. Onderstepoort J Vet Res 60:155–158, 1993. PUBMED Abstract
  80. Fulgêncio JQ, Go YY, Balasuriya UBR, et al: Serological evidence of equine arteritis virus infection in equidae of Minas Gerais, Brazil. in XXIIth Virology Brazilian Society (Sociedade Brasileira De Virologica), Atibaia, São Paulo, Brazil, 2011).
  81. De Boer GF, Osterhaus AD, van Oirschot JT, et al: Prevalence of antibodies to equine viruses in The Netherlands. Tijdschr Diergeneeskd 104(suppl):65–74, 1979. PUBMED Abstract
  82. Glaser AL, de Vries AA, Rottier PJ, et al: Equine arteritis virus: a review of clinical features and management aspects. Vet Q 18:95–99, 1996. PUBMED Abstract
  83. Eichhorn W, Heilmann M, Kaaden OR: Equine viral arteritis with abortions: serological and virological evidence in Germany. Zentralbl Veterinarmed B 42:573–576, 1995. PUBMED Abstract
  84. National Animal Health Monitoring System (NAHMS): Equine viral arteritis (EVA) and the US horse industry, Fort Collins, CO, 2000, US Department of Agriculture, Animal and Plant Health Inspection Service (VS, CEAH).
  85. Hullinger PJ, Gardner IA, Hietala SK, et al: Seroprevalence of antibodies against equine arteritis virus in horses residing in the United States and imported horses. J Am Vet Med Assoc 219:946–949, 2001. PUBMED Abstract
  86. Timoney PJ, McCollum WH, Murphy TW, et al: The carrier state in equine arteritis virus infection in the stallion with specific emphasis on the venereal mode of virus transmission. J Reprod Fertil Suppl 35:95–102, 1987. PUBMED Abstract
  87. Timoney PJ: Equine viral arteritis: epidemiology and control. J Equine Vet Sci 8:54–59, 1988.
  88. McCue PM, Hietala SK, Spensely MS, et al: Prevalence of equine viral arteritis in California horses. Calif Vet 45:24–26, 1991.
  89. McKenzie J: Survey of stallions for equine arteritis virus. Surveillance 17–18, 1996.
  90. Moraillon A, Moraillon R: Results of an epidemiological investigation on viral arteritis in France and some other European and African countries. Ann Rech Vet 9:43–54, 1978. PUBMED Abstract
  91. Burki FH, Nowotny N: Objective data plead to suspend import bans for seroreactors against equine arteritis virus except for breeder stallions. J Appl Anim Res 1:31–42, 1992.
  92. Go YY, Bailey E, Cook DG, et al: Genome-wide association study among four horse breeds identifies a common haplotype associated with in vitro CD3+ T cell susceptibility/resistance to equine arteritis virus infection. J Virol 85:13174–13184, 2011.
  93. Go YY: University of Kentucky, 2011.
  94. Hullinger PJ, et al: Passive transfer, rate of decay, and protein specificity of antibodies against equine arteritis virus in horses from a standardbred herd with high seroprevalence. J Am Vet Med Assoc 213:839–842, 1998. PUBMED Abstract
  95. Cole JR, Hall RF, Gosser HS, et al: Transmissibility and abortogenic effect of equine viral arteritis in mares. J Am Vet Med Assoc 189:769–771, 1986. PUBMED Abstract
  96. McCollum WH, Prickett ME, Bryans JT: Temporal distribution of equine arteritis virus in respiratory mucosa, tissues and body fluids of horses infected by inhalation. Res Vet Sci 12:459–464, 1971. PUBMED Abstract
  97. Timoney PJ, McCollum WH, Roberts AW, et al: Demonstration of the carrier state in naturally acquired equine arteritis virus infection in the stallion. Res Vet Sci 41:279–280, 1986. PUBMED Abstract
  98. Guthrie AJ, Howell PG, Hedges JF, et al: Lateral transmission of equine arteritis virus among Lipizzaner stallions in South Africa. Equine Vet J 35:596–600, 2003. PUBMED Abstract
  99. McCollum WH, Timoney PJ, Tengelsen LA: Clinical, virological and serological responses of donkeys to intranasal inoculation with the KY-84 strain of equine arteritis virus. J Comp Pathol 112:207–211, 1995. PUBMED Abstract
  100. McCollum WH: Pathologic features of horses given avirulent equine arteritis virus intramuscularly. Am J Vet Res 42:1218–1220, 1981. PUBMED Abstract
  101. Glaser AL, de Vries AA, Rottier PJ, et al: Equine arteritis virus: clinical symptoms and prevention. Tijdschr Diergeneeskd 122:2–7, 1997. PUBMED Abstract
  102. Broaddus CC, Balasuriya UB, Timoney PJ, et al: Infection of embryos following insemination of donor mares with equine arteritis virus infective semen. Theriogenology 76:47–60, 2011. PUBMED Abstract
  103. Vaala WE, Hamir AN, Dubovi EJ, et al: Fatal, congenitally acquired infection with equine arteritis virus in a neonatal Thoroughbred. Equine Vet J 24:155–158, 1992. PUBMED Abstract
  104. Del Piero F, Wilkins PA, Lopez JW, et al: Equine viral arteritis in newborn foals: clinical, pathological, serological, microbiological and immunohistochemical observations. Equine Vet J 29:178–185, 1997. PUBMED Abstract
  105. Carman S, Rae C, Dubovi E: Equine arteritis virus isolated from a standardbred foal with pneumonia. Can Vet J 29:937, 1988. PUBMED Abstract
  106. Wilkins PA, Del Piero F, Lopez J, et al: Recognition of bronchopulmonary dysplasia in a newborn foal. Equine Vet J 27:398, 1995. PUBMED Abstract
  107. Guthrie AJ, Howell PG, Hedges JF, et al: Lateral transmission of equine arteritis virus among Lipizzaner stallions in South Africa. Equine Vet J 35:596–600, 2003. PUBMED Abstract
  108. Holyoak GR, Little TV, McCollum WH, et al: Relationship between onset of puberty and establishment of persistent infection with equine arteritis virus in the experimentally infected colt. J Comp Pathol 109:29–46, 1993. PUBMED Abstract
  109. Neu SM, Timoney PJ, McCollum WH: Persistent infection of the reproductive tract in stallions experimentally infected with equine arteritis virus. In Equine Infectious Diseases V: Proceedings of the Fifth International Conference, 1987, pp 149–154.
  110. Huntington PJ, Ellis PM, Forman AJ, et al: Equine viral arteritis. Aust Vet J 67:429–431, 1990. PUBMED Abstract
  111. Little TV, Holyoak GR, McCollum WH, et al: Output of equine arteritis virus from persistently infected stallions is testosterone dependent. In Equine Infectious Diseases VI: Proceedings of the Sixth International Conference, 1992, pp 225–229.
  112. McCollum WH, Little TV, Timoney PJ, et al: Resistance of castrated male horses to attempted establishment of the carrier state with equine arteritis virus. J Comp Pathol 111:383–388, 1994. PUBMED Abstract
  113. McCollum WH, Timoney PJ: The pathogenic qualities of the 1984 strain of equine arteritis virus. In Proceedings of the Grayson Foundation International Conference of Thoroughbred Breeders Organizations, 1984, pp 34–44.
  114. Chirnside ED: Equine arteritis virus: an overview. Br Vet J 148:181–197, 1992. PUBMED Abstract
  115. Zhang J, Timoney PJ, Shuck KM, et al: Molecular epidemiology and genetic characterization of equine arteritis virus isolates associated with the 2006/2007 multi-state disease occurrence in the USA. J Gen Virol 91:2286–2301, 2010. PUBMED Abstract
  116. Fukunaga Y, Imagawa H, Tabuchi E, et al: Clinical and virological findings on experimental equine viral arteritis in horses. Bull Equine Res Inst 18:110–118, 1981.
  117. Jones TC: Clinical and pathologic features of equine viral arteritis. J Am Vet Med Assoc 155:315–317, 1969. PUBMED Abstract
  118. MacLachlan NJ, Balasuriya UB, Rossitto PV, et al: Fatal experimental equine arteritis virus infection of a pregnant mare: immunohistochemical staining of viral antigens. J Vet Diagn Invest 8:367–374, 1996. PUBMED Abstract
  119. McCollum WH: Responses of horses vaccinated with avirulent modified-live equine arteritis virus propagated in the E. Derm (NBL-6) cell line to nasal inoculation with virulent virus. Am J Vet Res 47:1931–1934, 1986. PUBMED Abstract
  120. McCollum WH: Pathologic features of horses given avirulent equine arteritis virus intramuscularly. Am J Vet Res 42:1218–1220, 1981. PUBMED Abstract
  121. Balasuriya UB, Dobbeb JC, Heidner HW, et al: Characterization of the virulence determinants of equine arteritis virus using an infectious cDNA clone derived from the virulent Bucyrus strain. Presented at Tenth International Nidovirus Symposium, 2005.
  122. Balasuriya UB, Heidner HW, Davis NL, et al: Alphavirus replicon particles expressing the two major envelope proteins of equine arteritis virus induce high level protection against challenge with virulent virus in vaccinated horses. Vaccine 20:1609–1617, 2002. PUBMED Abstract
  123. Bishop SP: Animal models of vasculitis. Toxicol Pathol 17:109–117, 1989. PUBMED Abstract
  124. Henson JB, Crawford TB: The pathogenesis of virus-induced arterial disease: Aleutian disease and equine viral arteritis. Adv Cardiol 13:183–191, 1974. PUBMED Abstract
  125. Coignoul FL, Cheville NF: Pathology of maternal genital tract, placenta, and fetus in equine viral arteritis. Vet Pathol 21:333–340, 1984. PUBMED Abstract
  126. Estes PC, Cheville NF: The ultrastructure of vascular lesions in equine viral arteritis. Am J Pathol 58:235–253, 1970. PUBMED Abstract
  127. Moore BD, Balasuriya UB, Watson JL, et al: Virulent and avirulent strains of equine arteritis virus induce different quantities of TNF-alpha and other proinflammatory cytokines in alveolar and blood-derived equine macrophages. Virol 314:662–670, 2003. PUBMED Abstract
  128. Go YY, Zhang J, Timoney PJ, et al: Complex interactions between the major and minor envelope proteins of equine arteritis virus determine its tropism for equine CD3+ T lymphocytes and CD14+ monocytes. J Virol 84:4898–4911, 2010. PUBMED Abstract
  129. Go YY, Cook RF, Fulgêncio JQ, et al: Assessment of correlation between in vitro CD3(+) T cell susceptibility to EAV infection and clinical outcome following experimental infection. Vet Microbiol 157:220–225, 2011. PUBMED Abstract
  130. Timoney PJ, Klingeborn B, Lucas MH: A perspective on equine viral arteritis (infectious arteritis of horses). Rev Sci Tech 15:1203–1208, 1996. PUBMED Abstract
  131. Balasuriya UB, Snijder EJ, van Dinten LC, et al: Equine arteritis virus derived from an infectious cDNA clone is attenuated and genetically stable in infected stallions. Virol 260:201–208, 1999. PUBMED Abstract
  132. Doll ER, Bryans JT, Wilson JC, et al: Immunization against equine viral arteritis using modified live virus propagated in cell cultures of rabbit kidney. Cornell Vet 48:497–524, 1968. PUBMED Abstract
  133. Swerczek TW, Crowe MW, Prickett ME, et al: Focal bacterial hepatitis in foals: preliminary report. Mod Vet Pract 54:66–67, 1973. PUBMED Abstract
  134. Bryans JT, Crowe ME, Doll ER, et al: The blood picture and thermal reaction in experimental viral arteritis of horses. Cornell Vet 47:42–52, 1957. PUBMED Abstract
  135. Neu SM, Timoney PJ, Lowry SR: Changes in semen quality following experimental equine arteritis virus infection in the stallion. Theriogenology 37:407–431, 1992.
  136. McCollum WH, Ozawa Y, Dardiri AH: Serologic differentiation between African horse-sickness and equine arteritis. Am J Vet Res 31:1963–1966, 1970. PUBMED Abstract
  137. Asagoe T, Inaba Y, Jusa ER, et al: Effect of heparin on infection of cells by equine arteritis virus. J Vet Med Sci 59:727–728, 1997. PUBMED Abstract
  138. Del Piero F: Diagnosis of equine arteritis virus infection in two horses by using monoclonal antibody immunoperoxidase histochemistry on skin biopsies. Vet Pathol 37:486–487, 2000. PUBMED Abstract
  139. Del Piero F: Equine viral arteritis. Vet Pathol 37:287–296, 2000. PUBMED Abstract
  140. Lopez JW, del Piero F, Glaser A, et al: Immunoperoxidase histochemistry as a diagnostic tool for detection of equine arteritis virus antigen in formalin fixed tissues. Equine Vet J 28:77–79, 1996. PUBMED Abstract
  141. Chirnside ED, Spaan WJ: Reverse transcription and cDNA amplification by the polymerase chain reaction of equine arteritis virus (EAV). J Virol Methods 30:133–140, 1990. PUBMED Abstract
  142. St-Laurent G, Morin G, Archambault D: Detection of equine arteritis virus following amplification of structural and nonstructural viral genes by reverse transcription–PCR. J Clin Microbiol 32:658–665, 1994. PUBMED Abstract
  143. Sekiguchi K, Sugita S, Fukunaga Y, et al: Detection of equine arteritis virus (EAV) by polymerase chain reaction (PCR) and differentiation of EAV strains by restriction enzyme analysis of PCR products. Arch Virol 140:1483–1491, 1995. PUBMED Abstract
  144. Gilbert SA, Timoney PJ, McCollum WH, et al: Detection of equine arteritis virus in the semen of carrier stallions by using a sensitive nested PCR assay. J Clin Microbiol 35:2181–2183, 1997. PUBMED Abstract
  145. Balasuriya UB, Leutenegger CM, Topol JB, et al: Detection of equine arteritis virus by real-time TaqMan reverse transcription–PCR assay. J Virol Methods 101:21–28, 2002. PUBMED Abstract
  146. Westcott DG, King DP, Drew TW, et al: Use of an internal standard in a closed one-tube RT-PCR for the detection of equine arteritis virus RNA with fluorescent probes. Vet Res 34:165–176, 2003. PUBMED Abstract
  147. Ramina A, Dalla Valle L, De Mas S, et al: Detection of equine arteritis virus in semen by reverse transcriptase polymerase chain reaction—ELISA. Comp Immunol Microbiol Infect Dis 22:187–197, 1999. PUBMED Abstract
  148. Miszczak F, Shuck KM, Lu Z, et al: Evaluation of two magnetic-bead-based viral nucleic acid purification kits and three real-time reverse transcription-PCR reagent systems in two TaqMan assays for equine arteritis virus detection in semen. J Clin Microbiol 49:3694–3696, 2011. PUBMED Abstract
  149. Lu Z, Branscum AJ, Shuck KM, et al: Comparison of two real-time reverse transcription polymerase chain reaction assays for the detection of Equine arteritis virus nucleic acid in equine semen and tissue culture fluid. J Vet Diagn Invest 20:147–155, 2008. PUBMED Abstract
  150. Senne DA, Pearson JE, Carbery EA: Equine viral arteritis: a standard procedure for the virus neutralization test and comparison of results of a proficiency test performed at five laboratories. In Proceedings of the 89th Annual Meeting of the United States Animal Health Association, 1985.
  151. Lenihan P: Use of the virus microneutralization (VN) test for equine arteritis virus (EAV) serology. International Workshop on the Diagnosis of Equine Arteritis Virus Infection, Lexington, KY, 2004, pp 52–53.
  152. Newton JR, Geraghty RJ, Castillo-Olivares J, et al: Evidence that use of an inactivated equine herpesvirus vaccine induces serum cytotoxicity affecting the equine arteritis virus neutralisation test. Vaccine 22:4117–4123, 2004. PUBMED Abstract
  153. Cook RF, Gann SJ, Mumford JA: The effects of vaccination with tissue culture–derived viral vaccines on detection of antibodies to equine arteritis virus by enzyme-linked immunosorbent assay (ELISA). Vet Microbiol 20:181–189, 1989. PUBMED Abstract
  154. Chirnside ED, Francis PM, de Vries AA, et al: Development and evaluation of an ELISA using recombinant fusion protein to detect the presence of host antibody to equine arteritis virus. J Virol Methods 54:1–13, 1995. PUBMED Abstract
  155. Hedges JF, Balasuriya UB, Ahmad S, et al: Detection of antibodies to equine arteritis virus by enzyme linked immunosorbent assays utilizing G(L), M and N proteins expressed from recombinant baculoviruses. J Virol Methods 76:127–137, 1998. PUBMED Abstract
  156. Cho HJ, Entz SC, Deregt D, et al: Detection of antibodies to equine arteritis virus by a monoclonal antibody–based blocking ELISA. Can J Vet Res 64:38–43, 2000. PUBMED Abstract
  157. Nugent J, Sinclair R, deVries AA, et al: Development and evaluation of ELISA procedures to detect antibodies against the major envelope protein (G(L)) of equine arteritis virus. J Virol Methods 90:167–183, 2000. PUBMED Abstract
  158. Starik E, Ginter A, Coppe P: ELISA and direct immunofluorescence test to detect equine arteritis virus (EAV) using a monoclonal antibody directed to the EAV-N protein. J Vet Med B Infect Dis Vet Public Health 48:1–9, 2001. PUBMED Abstract
  159. Wagner HM, Balasuriya UB, MacLachlan JN: The serologic response of horses to equine arteritis virus as determined by competitive enzyme-linked immunosorbent assays (c-ELISAs) to structural and non-structural viral proteins. Comp Immunol Microbiol Infect Dis 26:251–260, 2003. PUBMED Abstract
  160. Go YY, Wong SJ, Branscum AJ, et al: Development of a fluorescent-microsphere immunoassay for detection of antibodies specific to equine arteritis virus and comparison with the virus neutralization test. Clin Vaccine Immunol 15:76–87, 2008. PUBMED Abstract
  161. McCollum WT: Mesenteric thrombosis. Ann Intern Med 37:579–587, 1952. PUBMED Abstract
  162. Holyoak GR, Giles RC, McCollum WH, et al: Pathological changes associated with equine arteritis virus infection of the reproductive tract in prepubertal and peripubertal colts. J Comp Pathol 109:281–293, 1993. PUBMED Abstract
  163. Johnson B, Baldwin C, Timoney P, et al: Arteritis in equine fetuses aborted due to equine viral arteritis. Vet Pathol 28:248–250, 1991. PUBMED Abstract
  164. Holyoak GR, Little TV, Vernon M, et al: Correlation between ultrasonographic findings and serum testosterone concentration in prepubertal and peripubertal colts. Am J Vet Res 55:450–457, 1994. PUBMED Abstract
  165. Zhang J, Stein DA, Timoney PJ, et al: Curing of HeLa cells persistently infected with equine arteritis virus by a peptide-conjugated morpholino oligomer. Virus Res 150:138–142, 2010. PUBMED Abstract
  166. McCollum WH: Vaccination for equine viral arteritis. In Proceedings of the Second International Conference on Equine Infectious Diseases, Paris, 1969, S Karger, Basel, pp 143–151.
  167. Fukunaga Y, McCollum WH: Complement-fixation reactions in equine viral arteritis. Am J Vet Res 38:2043–2046, 1977. PUBMED Abstract
  168. MacLachlan NJ, Balasuriya UB, Hedges JF, et al: Serologic response of horses to the structural proteins of equine arteritis virus. J Vet Diag Invest 10:229–236, 1998. PUBMED Abstract
  169. Go YY, Snijder EJ, Timoney PJ: Characterization of equine humoral antibody response to the nonstructural proteins of equine arteritis virus. Clin Vaccine Immunol 18:268–279, 2011. PUBMED Abstract
  170. Castillo-Olivares J, Tearle JP, Montesso F, et al: Detection of equine arteritis virus (EAV)–specific cytotoxic CD8+ T lymphocyte precursors from EAV-infected ponies. J Gen Virol 84:2745–2753, 2003. PUBMED Abstract
  171. Harry TO, McCollum WH: Stability of viability and immunizing potency of lyophilized, modified equine arteritis live-virus vaccine. Am J Vet Res 42:1501–1505, 1981. PUBMED Abstract
  172. McKinnon AO, Colbern GT, Collins JK, et al: Vaccination of stallions with a modified live equine arteritis virus vaccine. J Equine Vet Sci 6:66–69, 1986.
  173. Timoney PJ, Umphenour NW, McCollum WH: Safety evluation of a commercial modified live equine artertis virus vaccine for use in stallions. In Powell DG, editor: Proceedings of the Fifth International Conference of Equine Infectious Diseases, Lexington, KY, 1988, The University Press of Kentucky, pp 19–27.
  174. Summers-Lawyer KA, Go YY, Lu Z, et al: Response of Stallions to primary immunization with a modified live equine viral arteritis vaccine. J Equine Vet Sci 31:10, 2011.
  175. Timoney PJ, Fallon L, Shuck K, et al: The outcome of vaccinating five pregnant mares with a commercial equine viral arteritis vaccine. Equine Vet Educ 19:6, 2007.
  176. Moore BD, Balasuriya UB, Nurton JP, et al: Differentiation of strains of equine arteritis virus of differing virulence to horses by growth in equine endothelial cells. Am J Vet Res 64:779–784, 2003. PUBMED Abstract
  177. Broaddus CC, Balasuriya UB, White JL, et al: Evaluation of the safety of vaccinating mares against equine viral arteritis during mid or late gestation or during the immediate postpartum period. J Am Vet Med Assoc 238:741–750, 2011. PUBMED Abstract
  178. McCollum WH: Studies of passive immunity in foals to equine viral arteritis. Vet Microbiol 1:45–54, 1976.
  179. McCollum WH, Timoney PJ, Roberts AW, et al: Response of vaccinated and non-vaccinated mares to artificial insemination with semen from stallions persistently infected with equine arteritis virus. In Equine Infectious Diseases V: Proceedings of the Fifth International Conference, 1987, pp 13–18.
  180. EVA vaccine granted animal test certificate. Vet Rec 133:26–27, 1993.
  181. Castillo-Olivares J, Wieringa R, Bakonyi T, et al: Generation of a candidate live marker vaccine for equine arteritis virus by deletion of the major virus neutralization domain. J Virol 77:8470–8480, 2003. PUBMED Abstract
  182. US Department of Agriculture, Animal and Plant Health Inspection Service: Equine viral arteritis: uniform methods and rules, effective April 19, 2004, pp 1–19.
  183. Timoney PJ: Factors influencing the international spread of equine diseases. Vet Clin North Am Equine Pract 16:537–551, 2000. PUBMED Abstract